- Commercialisation Matrix: gateway to a wealth of resources for commercial success
A tool to connect you to a wealth of government (state and federal), private sector, and tertiary sector resources to assist you with your commercialisation journey.
- The Medical Devices Financial Incentive Program (MDFIP) 2009
The Queensland Medical Devices Financial Incentive Program aims to promote new and innovative medical devices/technology for Queensland business to accelerate their potential access to the Queensland Health system. The devices must be developed or manufactured in Queensland.
The successful Queensland based companies are:
- ETS Mobility (a business initiative of the Cerebral Palsy League) for Pro-Fit, that uses software to make custom seating for people with significant skeletal deformities;
- NeuroTech Research P/L for Neuromathix, that uses software to more closely define specific drug delivery for patients, enhancing the therapeutic efficiency of medications;
- Diversionary Therapy Technologies P/L for Ditto, a hand-held device that alleviates pain and anxiety by diverting the attention of paediatric burns patients; and
- Inverness Medical Innovations Australia P/L for Panbio Dengue Early ELISA (Generation 2), a kit that aids the clinical diagnosis of dengue fever.
- The Medical Devices Innovation Roundtable 2009
The MDIR was held in August 2009. The purpose of the meeting was to help companies and stakeholders understand how to effectively engage with Queensland Health and understand the mechanisms and logistics associated with seeking future business opportunities with Queensland’s largest purchaser of medical devices. The project evolved from the Medical Devices Financial Incentive Program.
Outcomes from the day are being explored in the following categories:
- Product development - concept to reality
- Identifying the need - market engagement
- Purchasing the product - tender and contracts
Details to be provided in coming months.
- Queensland Medical Device Industry Analysis (sponsored by AusBiotech)
Fifteen medical device companies in Queensland participated in a survey designed to develop a profile of the industry needs and areas where government support could be provided. The survey participants included a range of companies at different stages of the product development pipeline (from prototype to exporting finished product), those manufacturing internally or outsourcing, those with Class 1, 2 or 2a products, annual turnovers ranging from less than $100k to over $5 million, revenue growth of zero to more than 30% per annum, those generating over 50% of their revenue from exports to those generating less than 5% and those employing less than 5 full-time equivalent (FTE) staff to more than 100 FTE.
The data gathered from the survey highlighted various issues that affect the growth and future of the industry.
Click here to download the Queensland Medical Device Industry Analysis Report.